Outperforming FY22E, promising FY23E and not-far-fetching FY25E target
3Q24 net profit +38% YoY, beat expectations; US remains the most promising market
Healthcare: Chinese biopharma releasing promising data at ASCO
–1H23 beat and promising outlook; Lift TP to HK$41.98
ASH takeaways: Three synergistic haematology BIC/FIC molecules showing promising data
Artificial Intelligence’s Promise and Peril
WEF_The_Promise_of_Platform_Work
Promise (Un)kept? Fintech and Financial Inclusion
Promising PoC results of the potential FIC asset
Climate Promise Progress Report